- Home
- GLMD vs CTHR Comparison
GLMD vs CTHR Comparison
Compare GLMD & CTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- CTHR
- Stock Information
- Founded
- GLMD 2000
- CTHR 1995
- Country
- GLMD Israel
- CTHR United States
- Employees
- GLMD N/A
- CTHR N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- CTHR Consumer Specialties
- Sector
- GLMD Health Care
- CTHR Consumer Discretionary
- Exchange
- GLMD Nasdaq
- CTHR Nasdaq
- Market Cap
- GLMD 4.5M
- CTHR 4.1M
- IPO Year
- GLMD 2014
- CTHR 1997
- Fundamental
- Price
- GLMD $2.70
- CTHR $1.41
- Analyst Decision
- GLMD
- CTHR
- Analyst Count
- GLMD 0
- CTHR 0
- Target Price
- GLMD N/A
- CTHR N/A
- AVG Volume (30 Days)
- GLMD 21.6K
- CTHR 10.5K
- Earning Date
- GLMD 04-03-2025
- CTHR 03-04-2025
- Dividend Yield
- GLMD N/A
- CTHR N/A
- EPS Growth
- GLMD N/A
- CTHR N/A
- EPS
- GLMD N/A
- CTHR N/A
- Revenue
- GLMD N/A
- CTHR $23,684,860.00
- Revenue This Year
- GLMD N/A
- CTHR $31.82
- Revenue Next Year
- GLMD N/A
- CTHR N/A
- P/E Ratio
- GLMD N/A
- CTHR N/A
- Revenue Growth
- GLMD N/A
- CTHR N/A
- 52 Week Low
- GLMD $2.24
- CTHR $1.16
- 52 Week High
- GLMD $23.80
- CTHR $4.30
- Technical
- Relative Strength Index (RSI)
- GLMD 49.41
- CTHR 46.53
- Support Level
- GLMD $2.24
- CTHR $1.28
- Resistance Level
- GLMD $2.72
- CTHR $1.40
- Average True Range (ATR)
- GLMD 0.20
- CTHR 0.07
- MACD
- GLMD 0.02
- CTHR -0.01
- Stochastic Oscillator
- GLMD 71.47
- CTHR 54.17
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
About CTHR Charles & Colvard Ltd
Charles & Colvard Ltd manufactures, markets, and distributes finished jewellery which also includes moissanite gemstone in the jewellery market. The company sells jewels through two operating segments namely Online Channels segment and Traditional segment. It generates maximum revenue from the Online Channels segment. Online Channels segment which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail, and other pure-play, exclusively e-commerce outlets.